Case Name (Date)

Fust et al. v. Gilead Sciences, Inc.
23-at-1244, E.D. Cal.
(Sept. 2023)


Product/Service

Remdesivir


Allegations

Falsely marketing Remdesivir as safe and effective against COVID-19 without disclosing its limitations and adverse events, including fatalities


Status

Pending



The Latest

Filters

Relivira

Ad Alert

Relivira

Underwear seller strips a number of marketing claims after a TINA.org inquiry.


Show More